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See ARTICLE page XX these exciting systems that the membrane form of lymphotoxin (LT) was recently inserted ( Figure 1 ).
In general, the LT system is a mechanism by which lymphocytes can instruct stromal cells to diff erentiate into specialized reticular networks and vasculature. Th ese elements form the portals that gate lymphocyte entry into organized sites and the frameworks that position cells for optimal encounters with antigen. 4 Th e LT motif is used in the gut during mesenteric lymph node and Peyer ' s patch development as well as to drive the generation and maturation of mucosal TLTs. Over a decade of work has linked the LT system to aspects of mucosal immunology, including M-cell differentiation, T-cell diff erentiation, ILFs, mucosal immunoglobulin (Ig)A production, oral tolerance, and pathology in rodent gastritis and colitis models. 5, 6 Th e current story warmed up in 2010 when a team led by Alexei Tumanov and Yang-Xin Fu followed up on an observation made by Thomas Spahn and colleagues in 2004 that mice lacking the surface LT (the LT / trimeric ligand) or its receptor, LT R, readily succumbed to a Citrobacter rodentium infection. 7, 8 C. rodentium infection is oft en used to explore the infl ammatory eff ects of an enteric pathogen and the host ' s immune response. Th ey found that LT expressed by ROR t + lymphocytes, i.e., ILC, was critical for lymphocyte communication to the epithelium and the recruitment of neutrophils to the damaged barrier. Direct signaling of LT ligand on lymphocytes to receptor-positive epithelial cells is certainly plausible based on the studies of lymphotoxin-receptor (LT R) agonism in colorectal carcinoma cells or hepatocytes in hepatitis. 9, 10 An important prequel to this saga was written in 2008 by Wenjun Ouyang ' s group at Genentech
The circus thrills the senses with unimaginable spectacles. By analogy, mucosal immunologists could identify the menagerie of participants going in and out of the circus tent, but have longed to view the show in its whole splendor. Over the last decade, the tent has been opening its doors revealing the amazing equilibrium between the immune system and commensal flora at the mucosal interface. Th e intestinal microenvironments need to establish homeostasis with the gut contents, yet respond, usually aggressively, to an imbalance or pathogen while preserving the ability of the gut to harvest nutrients. Having a key role in this Herculean task is a new class of lymphocytes called innate lymphoid cells (ILCs). 1, 2 One branch of this family is dependent upon the transcription factor ROR t for the development and includes the lymphoid tissue inducer cell (LTi), an " adult " LTi-like cell and a natural killer (NK) cell (NK22 or NKp46 + NK cell). Robust interleukin (IL)-17 or IL-22 secretion can be a trademark of these cells, yet they lack surface T-or B-cell receptors and hence are considered " innate " . Both cytokines trigger complex spectra of activity with both protective and proinfl ammatory components that appear to vary from organ to organ. 2 A second branch of ROR t-independent ILC has been described on the basis of Th 2-type cytokine secretion. Along with these discoveries, substantial progress has occurred in the understanding of the development and function of organized lymphoid environments. Adaptive immunological processes do not occur effi ciently without such structures and in the gut they include the developmentally determined draining lymph nodes and Peyer ' s patches as well as the non-predetermined tertiary lymphoid tissues (TLTs), i.e., isolated lymphoid follicles (ILF), cryptopatches, and cecal and colonic lymphoid patches (CLP, historically referred to simply as colonic patches). 3 It was into the intersection of
Lymphotoxin and the amazing technicolor circus of intestinal homeostasis
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Recently a new lymphocyte subset called innate lymphoid cells has emerged and it includes key producers of interleukin (IL)-17 and IL-22 in the mucosal environment. Using Citrobacter rodentium infection to deliver a pathogenic insult to the colon, two studies have revealed an underlying role for lymphotoxinreceptor signaling in the generation of IL-22 by these cells. This observation links a system well known for its ability to organize lymphoid microenvironments into a basic mucosal response.
nature publishing group COMMENTARIES in San Francisco, where they showed that early secretion of IL-22 was critical for survival following C. rodentium infection, and, moreover, IL-23 drove the expression of IL-22. 11 IL-22 triggers a complex gene expression program in epithelial cells with proinfl ammatory, chemokine secretion, production of anti-microbial proteins, and tissue repair components. Release of anti-microbial proteins such as RegIII helps to control the initial bacterial invasion. It was a quick leap in subsequent papers by both groups to show that IL-22 production was impaired in mice defi cient in the LT pathway. 12 -14 In both studies, the LT / ligand and not the alternative LT R ligand, LIGHT, was found to be responsible for the IL-23 / IL-22 eff ects and, moreover, LT ligand expression by ROR t + ILC was essential. While these rodent events were clearly LIGHT-independent, LIGHT has considerable history in the gut and its involvement in other mucosal settings may be more dramatic such as seen in the recent observations in the lung. 15 IL-22 is made by multiple cell types; however, the LTi is the dominant source in this setting. 2, 16 LT R is typically not present on lymphocytes, indicating indirect regulation of IL-22 production from LTi. Upon dissection, LT R signaling was required to induce the IL-23 that triggers the IL-22 response. 12 As dendritic cells are dominant producers of IL-23, an LT-dependent dialog between dendritic cells (DC) and ILC was postulated. Whether the role of LT R signaling is strictly limited to modulating DC production of IL-23 is less certain. A DC selective deletion of LT R resulted only in a partial exacerbation of C. rodentium infection and a modest twofold decrease in IL-23 production. 12 Moreover, the earlier work showed that LT R on both epithelium and hematopoietic cells was critical. 8 Th e work by Ota et al. 13 focused on the organized lymphoid architecture in the colon, i.e., CLP and ILF and the hypertrophy of these tissues that occurs following C. rodentium infection. Blockade of LT R signaling in mice infected with C. rodentium reduced the size and organization of these structures, an observation also made previously in another colitis setting. 17 Therefore, the role of LT R is likely a combination of maintaining TLT organization along with both ILC -DC and ILCepithelial communication. Th ese events could be intertwined with the control of chemo kine-induced positioning, perhaps involving CCL20 production.
Th e ability of LT R signaling to orchestrate cell traffi cking and positioning is well defi ned in both secondary and TLTs in normal and reactive states. It appears that there are several routes to TLT formation and organization including ROR t + ILC dependent and independent as well as LT dependent and independent mechanisms. In general, the formation of large TLT is LT-dependent, but recently, and of relevance to the gut, Th 17 cells were shown to trigger TLT formation in the lung. 18 Somewhat surprisingly, in the Ouyang study, IL-22 administration was able to restore robust TLT in the colon even in the presence of LT R blockade, suggesting that IL-22 can directly impact organization. It will be interesting to see how these IL-22-mediated events translate in colitis settings as infection models have considerable additional complexity. For example, the net impact of C. rodentium on host survival is a gemisch of colitis, eff ective host immune response, systemic spread of the infection and the kinetics of bacterial clearance. Pathogen clearance in LT-defi cient mice is impaired in many studies, presumably refl ecting alterations in basic adaptive immunology or effi cient antigen sensing. In general, the questions of whether the lack of LT R signaling led to an ineffi cient or slowed immune response and / or an unchecked infl ammatory response remain poorly explored. Second, LT R signaling is central to the diff erentiation of high endothelial venules and display of addressins in both secondary and tertiary settings. Th erefore, the traffi cking of various cells into the reactive sites should be altered in the absence of LT R signaling. Reduced traffi cking could be anti-infl ammatory, 
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nature publishing group yet also impair the host response to the pathogen. Finally, in several lymphoid tissues, the fi broblastoid reticular networks are aff ected by LT R signaling, and this element could be an important factor in the host response to C. rodentium . Indeed, LT R expression on mucosal nonhematopoietic cells is required for the development of gut IgA production. 19 Th ese data point toward a more intimate relationship between the ILC and DC in the mucosal niches, and there were some clues from prior studies. In what was a rather perplexing body of work; DC homeostasis or the maintenance of normal numbers of DCs in some secondary lymphoid organs was at least partially LT-dependent. 20 Recently, the diff erentiation of a DC subset in the spleen and gut was found to require Notch2 receptor signaling in an LT Rdependent manner. 21 Intriguingly, the diff erentiation of ROR t + ILC in the periphery is also Notch2-dependent and it will be interesting to learn if these two events are related. 22, 23 More poignantly, the idea of a DC -ILC dialog resonates well with a dissection of the roles of LT R and CD40 signaling in DC during adaptive T-cell responses, as elucidated in the work of Jen Gommerman and colleagues 24 in Toronto. In fact, their work started with the observation that DC-T cell clusters were disrupted following pharmacological blockade of LT R signaling. DC licensing for an adaptive T-cell response was found to require LT R signaling, and this function was non-redundant with CD40 signaling even though CD40 signaling is classically associated with DC licensing / maturation. Does the gut simply represent a similar dialog between more constitutively LT-positive ILC and DC? Non-canonical nuclear factor-B signaling is crucial for DC maturation / licensing and it is reasonable that LT R signaling could provide this element. 25 Human infl ammatory bowel disease (IBD) is viewed as a deviation from the normal balance between the microbiome and the mucosal immune system with a continuing cycle of infl ammation-triggered epithelial damage and excessive immune activation. How would an LT R inhibitory agent fare in this setting? It has been posited that many experimental therapies for IBD have been limited in effi cacy because a larger swath of the immunology needs to be brought under control. 26 Th e exaggerated dextran sulfate sodium colitis in the genetic absence of ROR t and hence lack of ILC certainly highlights the many roads to TLT formation and infl ammation. LT R inhibition attenuates disease in a wide range of mouse colitis models including an ROR t-independent setting. 4, 27 It can affect a broad range of immunological events, including the production of certain homeostatic chemokines, neutrophil-attracting chemokines released by epithelial cells, vascular addressin expression, reticular network specialization, the maintenance of large TLT, and now modulation of IL-22-triggered epithelial defense / repair programs. Th e consequences of IL-22 inhibition are diffi cult to forecast as IL-22 has both proinfl ammatory and repair roles depending on the organ and even diff ers between different IBD models. 2 Th us, there appears to be some pieces missing in this puzzle, such as a temporal component to the expression of IL-17 / IL-22 or perhaps the expression of the soluble IL-22 inhibitory receptor, Il22ra2, can resolve this conundrum. Whatever the exact details surrounding IL-22 ' s protective eff ects, LT R signaling appears to have a fundamental organizing role in the center ring of this circus. It will be exciting to see whether this LT R core function refl ects control of the spatial organization of the DC -ILC clusters or more direct ILC -DC or ILCepithelial signaling events. It is possible in IBD that LT R inhibition could reduce the amount of gut immunological activity at multiple levels, break the pathological cycle of commensal imbalance and barrier breach, and allow a " time-out " for the immune system to reset.
